Skip to main content

The Methods Section Should Not be an Afterthought in Scientific Papers

Many journals bury the Methods section at the end of papers, but for scientists trying to judge whether results can be trusted, that's exactly backwards.

Written byGad Gilad, PhD
| 3 min read
An illustration of a scientist sitting at a desk reading a paper document.
Register for free to listen to this article
Listen with Speechify
0:00
3:00

In experimental sciences, studies are only as good as the validity of the methods and materials used to perform their research. You ask a question, design a method, precisely document the results, and draw conclusions that can withstand scrutiny. Scientists who write papers describing their experiments want to publish their papers in scientific journals for the purpose of informing their peers of their findings. These other scientists want to know HOW the study was performed and what techniques were employed to ensure that the reported results are not only valid but also trustworthy. Arguably, this is the most crucial section for critical appraisal of an experimental research paper.

Word of the Wise: The Fundamental Principle of Scientific Progress

Reflecting on my early days in the laboratory as a graduate student at Cornell University, I remember the guiding principle of my advisor, Donald Reis. He stressed that what sets experimental scientists apart from other scientific disciplines is knowing how to methodically design well-controlled experiments to test our hypotheses. I still recall his words, “You must be absolutely sure that the methods you are using are reliable and reproducible, so that any changes you find occur only as a result of the experimental treatment you are studying and not because of inconsistencies in your methods.”

Continue reading below...

Like this story? Sign up for FREE Newsletter updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

In other words, in controlled experiments, changes in the outcome measurements, dependent variables (e.g., blood pressure, enzyme activity, etc.), occur strictly because of the experimental treatment under study, or independent variables, (e.g., manipulation of a specific dietary ingredient, drug, physical condition, etc.).

A fundamental principle of scientific progress is that published experimental studies should provide sufficient details so that reported results can be independently replicated by scientists in other laboratories. This is the reason why, in traditional scientific publications, the Methods section was placed after the Introduction section but before the Results and Discussion sections. This section order in scientific publications is referred to as IMRaD (Introduction, Methods, Results, and Discussion).

The Case Against Relegating the Methods Section to the End of Scientific Papers

Sometime at the end of the 1990s, several journal publishers, including Cell Press, Nature portfolio, Science titles, Proceedings of the National Academy of Sciences, rearranged the section order to relegate the Methods section to the end of the paper. I find that keeping the Methods section at the end is inconvenient and counterproductive, as it forces critical readers and reviewers to wander to the end of such publications to make sure the reported results are reliable.

Publishers reason that this section rearrangement—which is now pervasive among scientific journals—makes the papers they publish more engaging and accessible to a diverse readership who might skip the “tedious” Methods section. But most of these journals are discipline-specific. The target readership of experimental scientific papers is not a wider audience without specialized knowledge; rather, it is narrow and should remain focused on expert scientists within specified research fields.

The Abstract at the beginning of scientific papers serves the purpose of describing the background, methods, results and conclusions in a concise few-sentence outline. More recently, some journals also require an upfront “Highlights” paragraph that includes a limited number of bullet points of a few words each, summarizing the main findings and significance of the paper. These should be sufficient for allowing readers with scientific background to quickly grasp the essence of the paper. To reiterate, scientific papers should not be written for diverse readership or “broader” audiences. Enough avenues, including press releases, popular magazines, social media, and podcasts, are readily available today for publicizing scientific research in plain language, after scientific papers are properly written, reviewed, and published in science journals.

Many scientists regard moving the Methods section to the end of scientific papers as a glaring mistake. It is time for all science journals to revert to the traditional IMRaD section format in the publication of experimental studies. That some online journal publishers (such as PLOS or Frontiers) default to the traditional IMRaD format supports this concept. I think that universal reinstatement of the traditional format for original research articles would also have a favorable effect on the public image of all stakeholders involved in the scientific publication endeavor.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Gad Gilad wears a dark shirt against a light background in a headshot.

    Gad Gilad is a neuroscientist with a PhD from Cornell University. His research on neurotrauma and neurodegenerative diseases has resulted in over 100 peer reviewed scientific papers and several patents. One of his main achievements is the codiscovery of the neuroprotective and neuro-rescue properties of Agmatine, which led to its development as a valuable treatment for neuropathies and other conditions.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

​Beckman Coulter
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni

Products

Stellaromics Logo

Stellaromics Expands Pyxa Adoption as Instruments are Installed at Leading Research Institutions Across the U.S. and EuropeStellaromics, Inc., the leader in 3D

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform